Summary Marketline’s Corcept Therapeutics Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Corcept Therapeutics Incorporated since January2007.
Synopsis Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Key Highlights This report includes Corcept Therapeutics Incorporated’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Corcept Therapeutics Incorporated. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Scope - Provides intelligence on Corcept Therapeutics Incorporated’s M&A, strategic partnerships and alliances, capital raising and private equity transactions. - Detailed reports of various financial transactions undertaken by Corcept Therapeutics Incorporated and its subsidiaries since 2007. - Information about key financial and legal advisors for Corcept Therapeutics Incorporated’s financial deals transactions. - Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Reasons to buy - Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. - Form an independent opinion about Corcept Therapeutics Incorporated’s growth strategies through the organic and inorganic activities undertaken since 2007. - Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Drugs in Development, 2021 Summary Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) pipeline Target constitutes close to 6 molecules. Out of which approximately 4 molecules are developed by companies and...
162 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Stem Cells Market to Reach $15.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Stem Cells estimated at US$9.1 Billion in the year 2020, is projected to reach a revised size of US$15.1 Billion by 2027, growing at aCAGR of 7.4% over the period 2020-2027. Adult Stem Cells, one of...
171 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Personalized Medicines Market to Reach $515.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Personalized Medicines estimated at US$227.9 Billion in the year 2020, is projected to reach a revised size of US$515.3 Billion by 2027, growing at aCAGR of 12.4% over the period 2020-2027....
187 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Viscosupplementation Market to Reach $6.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for Viscosupplementation estimated at US$4 Billion in the year 2020, is projected to reach a revised size of US$6.8 Billion by 2027, growing at a CAGR of 7.7% over the analysis period 2020-2027....
376 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market to Reach $44.6 Billion by 2027
- Amid the COVID-19 crisis, the global market for Non-Small Cell Lung Cancer (NSCLC) Therapeutics estimated at US$20 Billion in the year 2020, is projected to reach a revised size of US$44.6 Billion by 2027, growing...
183 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Asthma Therapeutics Market to Reach $23.5 Billion by 2027
- Amid the COVID-19 crisis, the global market for Asthma Therapeutics estimated at US$21.8 Billion in the year 2020, is projected to reach a revised size of US$23.5 Billion by 2027, growing at a CAGR of 1.1% over the analysis period 2020-2027....
147 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global RNA-based Therapeutics and Vaccines Market to Reach $499 Million by 2027
- Amid the COVID-19 crisis, the global market for RNA-based Therapeutics and Vaccines estimated at US$14.7 Million in the year 2020, is projected to reach a revised size of US$499 Million by 2027, growing at aCAGR of 65.5% over...
125 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Vitiligo Therapeutics Market to Reach $2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Vitiligo Therapeutics estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 3.8% over the analysis period 2020-2027....
216 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Inflammatory Bowel Disease (IBD) Therapeutics Market to Reach $7.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Inflammatory Bowel Disease (IBD) Therapeutics estimated at US$6.8 Billion in the year 2020, is projected to reach a revised size of US$7.2 Billion by 2027, growing...